Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.
2.

Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome.

Mortola JF.

Clin Obstet Gynecol. 1993 Sep;36(3):753-63. Review.

PMID:
8403622
3.

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Pickar JH, Yeh I, Wheeler JE, Cunnane MF, Speroff L.

Fertil Steril. 2001 Jul;76(1):25-31.

PMID:
11438315
4.

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.

Pickar JH, Yeh IT, Wheeler JE, Cunnane MF, Speroff L.

Fertil Steril. 2003 Nov;80(5):1234-40.

PMID:
14607581
5.

The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.

Barrett-Connor E, Slone S, Greendale G, Kritz-Silverstein D, Espeland M, Johnson SR, Waclawiw M, Fineberg SE.

Maturitas. 1997 Jul;27(3):261-74.

PMID:
9288699
6.

Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.

Cedars MI, Lu JK, Meldrum DR, Judd HL.

Obstet Gynecol. 1990 Apr;75(4):641-5.

PMID:
2138265
7.

Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.

Sundström I, Nyberg S, Bixo M, Hammarbäck S, Bäckström T.

Acta Obstet Gynecol Scand. 1999 Nov;78(10):891-9.

PMID:
10577620
8.

The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.

Leather AT, Studd JW, Watson NR, Holland EF.

Gynecol Endocrinol. 1999 Feb;13(1):48-55.

PMID:
10368798
10.
11.

Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.

Björn I, Bäckström T, Lalos A, Sundström-Poromaa I.

Climacteric. 2006 Aug;9(4):290-7.

PMID:
16857659
13.

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E.

Obstet Gynecol. 1998 Dec;92(6):982-8.

PMID:
9840563
14.
15.

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.

Berga SL, Yen SS.

Clin Endocrinol (Oxf). 1989 Feb;30(2):177-84.

PMID:
2532984
16.

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E.

Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9.

PMID:
10068383
18.

The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial.

Tutuncu L, Ergur AR, Mungen E, Gun I, Ertekin A, Yergok YZ.

Menopause. 2005 Mar;12(2):216-22.

PMID:
15772570
19.

The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.

Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.

Climacteric. 2007 Oct;10(5):400-7.

PMID:
17852143

Supplemental Content

Support Center